The Calculation Agent announces that there will be no new constituents of the Nasdaq Crypto Index (NCI) when the index is rebalanced on September 1st, 2021. In accordance with the methodology, the constituents and their respective free float supplies as observed at 23:59:59 UTC, on August 23rd, 2021 are:
| Asset | Ticker | Free Float Supply |
|---|---|---|
| Bitcoin Cash | BCH | 12931921.32 |
| Bitcoin | BTC | 14968534.94 |
| Ethereum | ETH | 108216138.99 |
| Filecoin | FIL | 109379976.28 |
| Chainlink | LINK | 370358712.87 |
| Litecoin | LTC | 65230745.78 |
| Uniswap | UNI | 318193403.28 |
| Stellar Lumens | XLM | 15543928462.23 |
The reconstitution and rebalance of the NCI will take place on September 1st, 2021.
To view both the NCI Real Time Index and NCI Daily Settlement Price click here.
For further details on the Nasdaq Crypto Index click here.
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell any of the underlying instruments cited including but not limited to cryptoassets, financial instruments or any instruments that reference any index provided by CF Benchmarks Ltd. This communication is not intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. Please contact your financial adviser or professional before making an investment decision.
Note: Some of the underlying instruments cited within this material may be restricted to certain customer categories in certain jurisdictions.
Defensives took the board: Downside Beta swung from -3.42% to a +4.15% lead as Market fell 7.77%, Size's small-cap run unwound, and Liquidity snapped its losing streak.

Mark Pilipczuk
Notice of the Demising of CF IoTeX-Dollar Spot Rate

CF Benchmarks
Hyperliquid returns ~83 cents of every fee dollar to HYPE holders via buybacks, far more than Coinbase or Robinhood turn into profit. On fully diluted supply it trades near 61x earnings; our modeling assumes growing market share and puts fair value near $106, about 89% above the June 10 price.

Mark Pilipczuk
By clicking Accept, you consent to CF Benchmarks's use of cookies.
Visit Cookie Settings to learn how CF Benchmarks uses cookies and to adjust your preferences.